Value creation and transformation of SGD Pharma - PAI Partners

Contact us
Investor Login

About
Investments
ESG
Team
Media

Enter your search...

About
Investments
ESG
Team
Media

Contact us
Investor Login

Value creation and transformation of SGD Pharma

01 Oct 2024

Back

LinkedIn Twitter Email Facebook
Print

You might also be interested in

Videos

2025 Flagship & Mid-Market Funds Annual General Meetings
Videos

Leadership Voices – Episode 3: Creating Value
Videos

Leadership Voices – Episode 2: Carve-outs & Partnerships

About
Investments
ESG
Team
Media

© PAI 2025. | PAI Partners 2019 | PAI SAS: Registered in France No. 904 479 649, PAI SAS is a fund management company approved and regulated by the AMF in France (approval number GP-20240001). PAI Partners S.à r.l. : Registered in Luxembourg No. B136689. PAI Partners S.à r.l. is a fund management company approved and regulated by the CSSF in Luxembourg (approval number N. A00000625). PAI Partners (UK) Limited: Registered in the United Kingdom No 04015677. PAI Partners (UK) Limited is a financial advisory company approved and regulated by the FCA in the United Kingdom (approval number 984663). PAI and PAI Partners are registered trademarks.

Investor Login

Contact us
Terms & Conditions
Legal disclaimer
Cookie Policy
Accessibility
Privacy notice
Whistleblowing Policy